Evidence map›Paper›PMID 22394219›Full record

ReviewGrowth factors (Chur, Switzerland)2012

Ubiquitination-mediated regulation of interferon responses.

Serge Y Fuchs

Abstract readReview
In one paragraph

Review in Growth factors (Chur, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Disorders of ubiquitylation: unchained inflammation.Nature reviews. Rheumatology · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis ofJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A PotentClinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Serge Y FuchsDepartment of Animal Biology and Mari Lowe Comparative Oncology Center, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104-4539, USA. syfuchs@vet.upenn.edu

Funding

Role of HOS in Cell Transformation and ApoptosisR01CA092900 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FUCHS, SERGE Y · 2001 to 2021
$5.3M
Interferon Responses in Myeloid LeukemiaR01CA142425 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FUCHS, SERGE Y · 2010 to 2014
$1.6M
NCI NIH HHS CA092900NCI NIH HHS CA142425NCI NIH HHS R01 CA092900NCI NIH HHS R01 CA142425
6 · The paper itself

Abstract

Interferon cytokine family members shape the immune response to protect the host from both pathologic infections and tumorigenesis. To mediate their physiologic function, interferons evoke a robust and complex signal transduction pathway that leads to the induction of interferon-stimulated genes with both proinflammatory and antiviral functions. Numerous mechanisms exist to tightly regulate the extent and duration of these cellular responses. Among such mechanisms, the post-translational conjugation of ubiquitin polypeptides to protein mediators of interferon signaling has emerged as a crucially important mode of control. In this mini-review, we highlight recent advances in our understanding of these ubiquitin-mediated mechanisms, their exploitation by invading viruses, and their possible utilization for medical intervention.

Indexed as

Gene Expression RegulationSignal TransductionAmino Acid SequenceAnimalsHumansInterferonsMolecular Sequence DataUbiquitinUbiquitinationUbiquitin-Protein LigasesVirusesInterferonsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID22394219
PMCPMC3703147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.